151 material Form 8-K filings that 136 companies we cover made with the SEC in February 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Life360 reported 2023 revenue of $305 million, up 33% year over year, and a net loss of $28.2 million, down from $91.6 million in 2022. Adjusted EBITDA was $20.6 million, compared with negative $40.1 million a year earlier, and the company said it was its first full year of positive Adjusted EBITDA. For 2024, it guided to consolidated revenue of $365 million to $375 million and Adjusted EBITDA of $30 million to $35 million, and it announced a new advertising revenue stream.
2023 revenue of $305 million, up 33% year over year; company said this was in line with its guidance of $300 million to $310 million
Net loss of $28.2 million in 2023, an improvement of $63.5 million from 2022
Adjusted EBITDA of $20.6 million in 2023, versus negative $40.1 million in 2022
2024 guidance: revenue of $365 million to $375 million, Adjusted EBITDA of $30 million to $35 million, and year-end cash of $80 million to $90 million
Saul Centers reported fourth-quarter 2023 results on February 29, 2024, with total revenue up to $66.7 million from $62.3 million and net income available to common stockholders of $10.4 million, or $0.43 per share, versus $9.1 million, or $0.38, a year earlier. Diluted FFO per share was $0.79 compared with $0.72, and the filing shows the gains came mainly from higher termination fees and base rent.
Q4 2023 total revenue rose to $66.7 million from $62.3 million; net income rose to $17.5 million from $15.4 million.
Net income available to common stockholders was $10.4 million ($0.43 per basic and diluted share) vs. $9.1 million ($0.38) in Q4 2022.
Diluted FFO per share was $0.79 vs. $0.72; full-year 2023 diluted FFO per share was $3.12 vs. $3.04.
Same property operating income rose 8.8% in the quarter; commercial portfolio 94.2% leased at December 31, 2023 vs. 93.2%.
Arlo Technologies reported fourth-quarter 2023 revenue of $135.1 million, up 14.0% year over year, and GAAP net earnings of $0.01 per diluted share, compared with a loss of $0.25 a year earlier. For the full year, revenue was $491.2 million and GAAP net loss per share narrowed to $(0.24) from $(0.65). The company also gave first-quarter 2024 revenue guidance of $117 million to $127 million.
Q4 2023 revenue of $135.1 million, up 14.0% year over year; service revenue of $55.9 million, up 45.9%
Q4 2023 GAAP EPS of $0.01 and non-GAAP EPS of $0.11, versus GAAP loss of $(0.25) in Q4 2022
FY2023 revenue of $491.2 million, a slight increase; GAAP net loss per share of $(0.24) versus $(0.65) in 2022
Q1 2024 outlook: revenue of $117 million to $127 million; GAAP EPS of $(0.08) to $(0.02)
Vericel reported fourth-quarter and full-year 2023 results, with total revenue up 23% to $65.0 million in the quarter and up 20% to $197.5 million for the year. The company also issued 2024 guidance calling for total net revenue of $237 to $241 million, a gross margin of approximately 70%, and an adjusted EBITDA margin of approximately 20%. Shareholders get a view of stronger quarterly profit and a narrower full-year net loss, along with the company's first full-year revenue outlook in this release.
Q4 2023 net income was $13.0 million, or $0.26 per diluted share, versus $5.9 million, or $0.12 per diluted share, in Q4 2022.
Full-year 2023 net loss was $3.2 million, or $0.07 per diluted share, compared with a net loss of $16.7 million, or $0.35 per diluted share, in 2022.
MACI net revenue was $164.8 million for 2023, up 25%; Burn Care net revenue was $32.7 million.
As of December 31, 2023, the company had $152.6 million in cash, restricted cash and investments and no debt.
Strategic Education reported fourth-quarter 2023 revenue of $302.7 million, up 12.1% from a year earlier, and diluted earnings per share of $1.63 versus $0.77. Net income for the quarter was $39.1 million, compared with $18.3 million in the fourth quarter of 2022. The company also declared a regular quarterly dividend of $0.60 per share.
Q4 2023 revenue rose 12.1% to $302.7 million; net income was $39.1 million versus $18.3 million
Diluted EPS was $1.63 versus $0.77; adjusted diluted EPS was $1.68 versus $0.78 (non-GAAP)
Full-year 2023 revenue rose 6.3% to $1.13 billion; full-year diluted EPS was $2.91 versus $1.94
Quarterly dividend of $0.60 per share is payable March 18, 2024 to holders of record as of March 11, 2024
MYR Group reported fourth-quarter and full-year 2023 results on February 28, 2024, with full-year contract revenues of $3.64 billion, up 21.1 percent, and full-year net income of $91.0 million, or $5.40 per diluted share, up from $4.91 a year earlier. Fourth-quarter net income was $24.0 million, or $1.43 per diluted share, down from $1.46 in the same quarter of 2022, while fourth-quarter revenue rose 16.2 percent. The company's backlog was $2.51 billion at December 31, 2023.
Q4 2023 revenue was $1.00 billion, up $140.2 million or 16.2 percent from Q4 2022
Full-year 2023 net income was $91.0 million, or $5.40 per diluted share, versus $83.4 million, or $4.91 per diluted share, in 2022
Full-year gross margin fell to 10.0 percent from 11.4 percent, while Q4 net income declined 2.2 percent
Backlog was $2.51 billion at December 31, 2023, compared with $2.62 billion at September 30, 2023
TG Therapeutics reported fourth quarter and full year 2023 results, furnished as Exhibit 99.1 to a Form 8-K. Full-year total revenue was $233.7 million, including a $140.0 million one-time payment from Neuraxpharm, and the company swung to net income of $12.7 million from a $198.3 million net loss in 2022. The company also set a 2024 BRIUMVI U.S. net product revenue target of $220 million to $260 million, giving shareholders a benchmark for future results.
Q4 2023 total revenue was $44.0 million versus $80 thousand in Q4 2022; Q4 net loss narrowed to $14.4 million from $53.0 million.
Full-year 2023 BRIUMVI U.S. net product revenue was $88.8 million; license, milestone and other revenue was $141.7 million, mainly from the $140.0 million Neuraxpharm payment received in July 2023.
2024 targets: BRIUMVI U.S. net product revenue of approximately $220 million to $260 million and total operating expense of approximately $250 million.
Year-end 2023 cash, cash equivalents and investment securities were $217.5 million.
Warby Parker reported fourth quarter and full year 2023 results on February 28, 2024. Full year net revenue rose 12.0% to $669.8 million, and the GAAP net loss narrowed to $63.2 million from $110.4 million in 2022. The company also guided to 2024 net revenue of $748 million to $758 million, about 12% to 13% growth, and adjusted EBITDA of about $67 million at the revenue midpoint.
Full year 2023 net revenue increased 12.0% to $669.8 million; fourth quarter net revenue rose 10.5% to $161.9 million.
Full year GAAP net loss was $63.2 million, versus $110.4 million in 2022; fourth quarter GAAP net loss was $19.0 million.
2024 outlook: net revenue of $748 million to $758 million and adjusted EBITDA of $67 million at the revenue midpoint, with 40 new store openings planned.
Gross margin fell to 54.5% from 57.0% in 2022, which the company attributed mainly to growth in lower-margin contact lenses.
Chemed reported fourth-quarter 2023 revenue of $585.9 million, up 7.2%, with GAAP diluted EPS of $5.90, up 42.9%, and adjusted diluted EPS of $6.60, up 35.0%. The company gave 2024 adjusted diluted EPS guidance of $23.30 to $23.70, compared with $20.30 in 2023, while Roto-Rooter revenue fell 1.1% in the quarter.
Q4 2023 revenue rose 7.2% to $585.9 million; GAAP diluted EPS was $5.90 and adjusted diluted EPS was $6.60
VITAS net patient revenue rose 13.6% to $350.0 million; Roto-Rooter revenue fell 1.1% to $235.9 million
2024 guidance: adjusted diluted EPS of $23.30 to $23.70 versus $20.30 adjusted EPS in 2023
As of December 31, 2023, cash and cash equivalents were $264.0 million with no current or long-term debt
Protagonist Therapeutics reported fourth-quarter 2023 net income of $27.3 million, or $0.44 per diluted share, compared with a net loss of $34.2 million in the same quarter of 2022. Revenue came from $60 million in JNJ-2113 milestones, while the full-year net loss narrowed to $79.0 million from $127.4 million.
Q4 2023 license and collaboration revenue was $60 million, versus zero in Q4 2022, from milestones tied to JNJ-2113.
Full-year 2023 net loss was $79.0 million, or $1.39 per share, compared with $127.4 million, or $2.60 per share, in 2022.
Cash, cash equivalents and marketable securities were $341.6 million as of December 31, 2023, up from $237.4 million a year earlier.
Republic Services reported fourth-quarter 2023 net income of $439.6 million, or $1.39 per diluted share, up from $1.09 a year earlier, on revenue of $3,831.6 million, up 8.6 percent. For 2024 it expects adjusted diluted EPS of $5.94 to $6.00, compared with adjusted EPS of $5.61 for 2023, and revenue of $16.100 billion to $16.200 billion.
Q4 2023 revenue was $3,831.6 million, up 8.6 percent, including 2.9 percent growth from acquisitions.
Q4 2023 adjusted EPS was $1.41, up from $1.13; full-year 2023 adjusted EPS was $5.61, up from $4.93.
2024 guidance: adjusted EBITDA of $4.825 billion to $4.875 billion and adjusted free cash flow of $2.100 billion to $2.150 billion.
Quarterly dividend of $0.535 per share is payable April 15, 2024, to holders of record on April 2, 2024.
Erie Indemnity reported fourth-quarter 2023 net income of $110.9 million, or $2.12 per diluted share, up from $65.5 million, or $1.25, a year earlier. Full-year 2023 net income was $446.1 million, or $8.53 per diluted share, compared with $298.6 million, or $5.71, in 2022. The board also approved a quarterly Class A dividend of $1.275 per share, up from $1.190 a year earlier.
Q4 2023 total operating revenue was $817.7 million, up from $700.6 million in Q4 2022
Q4 2023 operating income rose 56.1% to $127.1 million, per the filing's highlights
Board approved Class A dividend of $1.275 per share, with a record date of April 9, 2024 and payable date of April 23, 2024
Results will be discussed in a pre-recorded webcast on February 27, 2024 at 10:00 a.m. ET
Berkshire Hathaway reported fourth-quarter 2023 net earnings attributable to shareholders of $37.6 billion, up from $18.1 billion a year earlier, and operating earnings of $8.5 billion, up from $6.6 billion. Investment and derivative gains of $29.1 billion made up most of the net earnings increase, and the company says investment gains in any quarter are usually not indicative of business performance. For the full year, net earnings were $96.2 billion compared with a loss of $22.8 billion in 2022.
Q4 2023 net earnings of $37.6 billion versus $18.1 billion in Q4 2022, including investment and derivative gains of $29.1 billion
Q4 2023 operating earnings of $8.5 billion versus $6.6 billion; insurance-underwriting earnings rose to $848 million from $160 million
Full-year 2023 net earnings of $96.2 billion versus a $22.8 billion loss in 2022; full-year operating earnings of $37.4 billion versus $30.9 billion
Berkshire repurchased about $2.2 billion of its shares in Q4 2023 and about $9.2 billion for the full year
Krystal Biotech reported fourth-quarter and full-year 2023 results, with net product revenue of $42.1 million in the quarter and $50.7 million for the year from VYJUVEK, which was approved in May 2023. The company posted net income of $8.7 million for the quarter versus a $32.1 million loss a year earlier, and $10.9 million for the year, which includes a $100.0 million gain from selling a Priority Review Voucher. The company also gave 2024 non-GAAP R&D and SG&A expense guidance of $150.0 million to $175.0 million.
Q4 2023 net product revenue was $42.1 million, versus no product revenue in Q4 2022.
Q4 2023 net income was $8.7 million ($0.31 per basic share), compared with a loss of $32.1 million in Q4 2022.
Full-year 2023 net income was $10.9 million, including a $100.0 million gain from the sale of a Priority Review Voucher.
2024 non-GAAP combined R&D and SG&A expense guidance is $150.0 million to $175.0 million; cash and investments were $594.1 million at December 31, 2023.
Penumbra reported fourth-quarter 2023 revenue of $284.7 million, up 28.7%, and GAAP net income of $54.2 million, or $1.38 per diluted share, which includes a $25.5 million tax benefit from a valuation allowance release. For 2024, the company projects total revenue of $1,230.0 million to $1,270.0 million, or 16% to 20% growth, and expects U.S. thrombectomy revenue to grow 27% to 30%.
Q4 2023 revenue was $284.7 million, up 28.7%; thrombectomy revenue was $190.8 million, up 42.4%
Q4 2023 GAAP net income was $54.2 million, or $1.38 per diluted share, including a $25.5 million tax benefit
Full-year 2023 revenue was $1,058.5 million, up 25.0%, and GAAP income from operations was $73.6 million versus $6.1 million in 2022
2024 revenue is projected at $1,230.0 million to $1,270.0 million, or 16% to 20% growth over 2023
Edison International reported fourth-quarter 2023 core earnings per share of $1.28, up from $1.15 a year earlier, while GAAP EPS fell to $0.99 from $1.09. For the full year, core EPS was $4.76 versus $4.63 in 2022, and the company introduced 2024 EPS guidance of $4.75 to $5.05 and reiterated its long-term EPS growth targets of 5% to 7%.
Q4 2023 core EPS of $1.28 vs. $1.15; GAAP EPS of $0.99 vs. $1.09; Q4 net income of $378 million vs. $415 million
Full-year 2023 core EPS of $4.76 vs. $4.63 in 2022; GAAP EPS of $3.12 vs. $1.61
2024 EPS guidance of $4.75 to $5.05, with core and basic EPS guidance equal
Quarterly common stock dividend of $0.78 per share, payable April 30, 2024, to holders of record on March 28, 2024
Valaris reported fourth quarter 2023 results in a press release dated February 21, 2024. Revenue rose to $484 million from $455 million in the third quarter, and net income rose to $829 million, which included a $790 million tax benefit, while the board doubled the share repurchase authorization to $600 million from $300 million.
Net income was $829 million in Q4 2023, up from $17 million in Q3 2023, including a $790 million tax benefit
Revenue rose to $484 million from $455 million; Adjusted EBITDA rose to $58 million from $40 million
Total contract backlog was more than $3.9 billion as of February 15, 2024, and the share repurchase authorization was raised to $600 million from $300 million
TechnipFMC reported fourth-quarter 2023 revenue of $2.08 billion, up 22.6% from a year earlier, and diluted earnings of $0.12 per share, compared with a loss of $0.06 a year earlier. Sequentially, revenue rose 1.0%, while adjusted EBITDA fell 7.9% and diluted EPS fell from $0.20 in the third quarter. The company also issued 2024 guidance, including Subsea revenue of $7.2 to $7.6 billion, giving shareholders a view of expected results for the year.
Q4 2023 revenue was $2,077.7 million, up 22.6% year over year and 1.0% from the third quarter.
Diluted EPS was $0.12, versus a loss of $0.06 a year earlier and $0.20 in the third quarter of 2023.
Adjusted EBITDA was $218.7 million, up 80.9% year over year but down 7.9% from the third quarter.
2024 guidance: Subsea revenue of $7.2 to $7.6 billion and Surface Technologies revenue of $1.2 to $1.35 billion.
St. Joe reported fourth-quarter and full-year 2023 results on February 21, 2024. Full-year revenue rose 54% to $389.2 million and net income attributable to the company rose 10% to $77.7 million, but fourth-quarter net income fell to $13.2 million from $28.1 million a year earlier. The board also declared a quarterly dividend of $0.12 per share.
Full-year 2023 revenue was $389.2 million, up from $252.3 million in 2022; net income attributable to the company was $77.7 million, or $1.33 per share, versus $70.9 million, or $1.21 per share.
Fourth-quarter 2023 revenue rose 41% to $86.7 million, but net income attributable to the company fell to $13.2 million, or $0.23 per share, from $28.1 million, or $0.48 per share.
The board declared a $0.12 per share cash dividend, payable March 27, 2024, to shareholders of record as of March 4, 2024.
Full-year 2022 net income included about $16.2 million after-tax gain on the Sea Sound Apartments sale and about $7.3 million after-tax gain on insurance recoveries.
RingCentral reported fourth-quarter 2023 total revenue of $571 million, up 9% year over year, and a GAAP net loss of $0.50 per share, compared with $2.97 a year earlier. Non-GAAP diluted EPS rose to $0.86 from $0.60, and the company gave full-year 2024 total revenue guidance of $2.370 billion to $2.395 billion with non-GAAP EPS of $3.50 to $3.58. Net cash from operating activities in the quarter was $114 million, which the company called a record for a fourth quarter.
Q4 2023 total revenue was $571 million, up from $525 million, a 9% increase.
GAAP operating loss narrowed to ($45) million from ($256) million; non-GAAP operating margin was 20.5%.
Q4 2023 net cash provided by operating activities was a record $114 million; cash and cash equivalents ended the quarter at $222 million.
FY2024 guidance: total revenue of $2.370 to $2.395 billion and non-GAAP EPS of $3.50 to $3.58.
National Presto reported 2023 net sales of $340.9 million, up 6.0%, and net earnings of $34.6 million ($4.86 per share), up from $20.7 million ($2.92 per share) in 2022. The Board also declared a 2024 dividend of $1.00 regular plus $3.50 extra per share, and disclosed two Defense segment awards totaling $44.2 million.
Net sales rose to $340.9 million from $321.6 million, led by a $39.2 million increase in Defense segment sales.
Net earnings were $34.6 million ($4.86 per share), compared with $20.7 million ($2.92 per share) in 2022.
2024 dividend is $1.00 regular plus $3.50 extra per share; record date March 1, 2024, payment date March 15, 2024.
Two Defense awards totaling $44.2 million cover 40mm cartridges for Ukraine and Small Diameter Bomb warheads, with completion scheduled for 2024.
Tootsie Roll reported fourth-quarter 2023 net sales of $195.4 million, up 4% from a year earlier, and net earnings of $29.4 million, with earnings per share of $0.42 versus $0.36. For the full year, net sales rose 12% to $763.3 million and earnings per share were $1.32 versus $1.07. Management said significantly higher input costs offset much of the benefit of the higher sales, and that margins have not yet returned to historical levels.
Q4 2023 net sales were $195,368,000 versus $188,180,000 in Q4 2022, an increase of 4%.
Q4 2023 net earnings were $29,403,000 versus $25,344,000; EPS was $0.42 versus $0.36, up 17%.
Full-year 2023 net sales were $763,252,000, up 12%; net earnings were $91,912,000 and EPS was $1.32 versus $1.07.
Management said higher ingredient, packaging and labor costs offset much of the sales benefit, and gross profit margins have not yet been restored to historical levels.
Visteon reported fourth-quarter and full-year 2023 results, with full-year net sales of $3.95 billion, up 5%, and record adjusted EBITDA of $434 million. Fourth-quarter net sales fell to $990 million from $1.06 billion, and fourth-quarter net income of $366 million included a $313 million non-cash U.S. tax benefit. The company also guided 2024 sales of $4.0 billion to $4.2 billion and adjusted EBITDA of $470 million to $500 million, and extended CEO Sachin Lawande's employment agreement through September 30, 2030.
Full-year 2023 net sales of $3.95 billion, up 5%; full-year net income of $486 million, or $17.05 per diluted share
Fourth-quarter net sales of $990 million, down from $1,064 million a year earlier, mainly due to lower semiconductor supply recoveries
2024 guidance: sales of $4.0 billion to $4.2 billion, adjusted EBITDA of $470 million to $500 million, adjusted free cash flow of $155 million to $185 million
Employment agreement with CEO Sachin Lawande extended to September 30, 2030; base salary set at $1,150,000 effective April 1, 2024
InterDigital reported fourth quarter and full year 2023 results, with full year revenue of $549.6 million, up 20%, and diluted earnings per share of $7.62 versus $3.07 a year earlier. The company guided full year 2024 revenue to $620 million to $670 million, but fourth quarter revenue fell 10% year over year, so shareholders will weigh the growth outlook against that quarterly decline.
Full year 2023 revenue was $549.6 million, up 20% from $457.8 million; GAAP diluted EPS was $7.62 versus $3.07.
Fourth quarter 2023 revenue was $105.5 million, down 10% from $117.1 million; GAAP diluted EPS was $1.41 versus $1.08.
Full year 2024 revenue is guided to $620 million to $670 million; first quarter 2024 revenue is guided to $245 million to $255 million.
The company returned $379.0 million to shareholders in 2023, including $339.7 million in share repurchases.
Curtiss-Wright reported fourth-quarter 2023 sales of $786 million, up 4%, and diluted EPS of $3.11 versus $2.82 a year earlier. For full-year 2023, sales rose 11% to $2.8 billion and diluted EPS was $9.20 versus $7.62. The company also issued 2024 guidance calling for diluted EPS of $10.00 to $10.30 and sales of $2,960 million to $3,010 million.
Q4 2023 reported sales of $786 million, up 4%; reported diluted EPS of $3.11 versus $2.82
Full-year 2023 reported sales of $2.8 billion, up 11%; diluted EPS of $9.20 versus $7.62
2024 guidance: sales of $2,960 million to $3,010 million, diluted EPS of $10.00 to $10.30, free cash flow of $415 million to $435 million
Full-year 2023 share repurchases of $50 million; quarterly dividend of $0.20 per share; conference call on February 15, 2024 at 10:00 a.m. ET
NMI Holdings reported fourth-quarter 2023 net income of $83.4 million, or $1.01 per diluted share, up from $72.9 million, or $0.86, a year earlier. For the full year, net income was $322.1 million, or $3.84 per diluted share, compared with $292.9 million, or $3.39, in 2022. Results were slightly below the third quarter in net income terms, but per-share earnings were higher than in both the prior quarter and the prior year.
Q4 2023 net income was $83.4 million, or $1.01 per diluted share, versus $72.9 million, or $0.86, in Q4 2022 and $84.0 million, or $1.00, in Q3 2023.
Full-year 2023 net income was $322.1 million, or $3.84 per diluted share, versus $292.9 million, or $3.39, in 2022.
Primary insurance-in-force was $197.0 billion at December 31, 2023, up from $184.0 billion a year earlier.
Book value per share excluding net unrealized gains and losses was $25.54, up from $21.76 at December 31, 2022.
Healthcare Services Group reported fourth-quarter 2023 GAAP net income of $22.6 million, or $0.31 per diluted share, up from $16.2 million, or $0.22, a year earlier. GAAP revenue was $423.8 million, roughly flat compared with $424.0 million in the prior-year quarter, and the company expects first-quarter 2024 revenue of $420.0 million to $430.0 million, so shareholders see higher profit on essentially unchanged sales.
Q4 2023 GAAP net income was $22.6 million, or $0.31 per diluted share, versus $16.2 million, or $0.22, in Q4 2022.
Q4 2023 GAAP revenue was $423.8 million, compared with $424.0 million in Q4 2022; adjusted revenue was $425.0 million.
Q4 2023 adjusted EBITDA was $26.5 million, a 14.2% increase over Q4 2022, and cash flow from operations was $49.5 million.
The company estimates first-quarter 2024 revenue in the range of $420.0 million to $430.0 million and repurchased $11.2 million of stock in 2023.
Urban Edge Properties reported fourth-quarter and full-year 2023 results on February 14, 2024, showing net income attributable to common shareholders of $221.2 million for the quarter versus $13.7 million a year earlier. The company also issued 2024 guidance and raised its quarterly dividend 6.25% to $0.17 per share, which matters to shareholders because it reflects both a sharp rise in reported profit and a higher payout.
Q4 2023 net income attributable to common shareholders was $221.2 million, or $1.88 per diluted share, versus $13.7 million, or $0.12 per diluted share, in Q4 2022.
FY 2023 FFO as Adjusted rose to $1.25 per diluted share from $1.21 in 2022, an increase of 3.3% per share.
2024 guidance projects net income of $0.12 to $0.17 per diluted share, FFO of $1.20 to $1.25 per diluted share, and FFO as Adjusted of $1.24 to $1.29 per diluted share.
Board declared a $0.17 quarterly dividend on February 13, 2024, payable March 29, 2024 to holders of record on March 15, 2024.
Mercury General reported fourth-quarter 2023 net income of $191.4 million, or $3.46 per diluted share, compared with a net loss of $6.8 million, or $0.12 per share, a year earlier. For full-year 2023, net income was $96.3 million, or $1.74 per diluted share, versus a net loss of $512.7 million in 2022, and the combined ratio improved to 105.4% from 108.7%. The company also said it cannot yet estimate losses from California atmospheric river storms in early 2024, which it expects to record in the first quarter of 2024.
Q4 2023 net income $191.4 million ($3.46 per diluted share) vs. net loss $6.8 million ($0.12 per share) in Q4 2022
Q4 2023 net premiums earned rose 13.9% to $1.14 billion; combined ratio improved to 98.6% from 115.8%
Full-year 2023 net income $96.3 million ($1.74 per share) vs. net loss $512.7 million in 2022
Board declared a quarterly dividend of $0.3175 per share, payable March 27, 2024 to holders of record March 13, 2024
Datadog reported fourth-quarter 2023 revenue of $589.6 million, up 26% from a year earlier, and full-year 2023 revenue of $2.13 billion, up 27%. GAAP net income for the quarter was $54.0 million, compared with a loss of $29.0 million in the same quarter of 2022. The company also gave 2024 guidance of $2.555 billion to $2.575 billion in full-year revenue and $587 million to $591 million in first-quarter revenue.
Q4 2023 revenue was $589.6 million, up 26% year-over-year; GAAP diluted EPS was $0.15 versus a loss of $0.09 a year earlier.
Full-year 2023 revenue was $2.13 billion, up 27%, with operating cash flow of $660.0 million and free cash flow of $597.5 million.
First-quarter 2024 revenue outlook is $587 million to $591 million; full-year 2024 revenue outlook is $2.555 billion to $2.575 billion.
Customers with ARR of $1 million or more rose to 396 from 317 a year earlier, a 25% increase.
Doximity reported fiscal third-quarter results for the quarter ended December 31, 2023, with revenue of $135.3 million, up 17%, net income of $48.0 million, up from $33.5 million, and adjusted EBITDA of $73.3 million, up 32%. The company also updated its fiscal 2024 guidance, with full-year revenue now expected between $473.3 million and $474.3 million, and CEO Jeff Tangney called the quarter a "beat and raise" on both top and bottom lines.
Revenue of $135.3 million, versus $115.3 million a year earlier, an increase of 17%.
Net income of $48.0 million, or $0.24 diluted per share, versus $33.5 million, or $0.16, a year earlier.
Fiscal fourth-quarter guidance: revenue of $115.9 million to $116.9 million and adjusted EBITDA of $50.5 million to $51.5 million.
Fiscal 2024 guidance updated to revenue of $473.3 million to $474.3 million and adjusted EBITDA of $224.5 million to $225.5 million.
Snap-on reported fourth-quarter 2023 net sales of $1,196.6 million, up 3.5%, and diluted earnings per share of $4.75, up 7.5% from $4.42 a year earlier. For the full year, diluted EPS was $18.76, up 11.5%, on net sales of $4,730.2 million. The company also projected 2024 capital expenditures of $100 million to $110 million and an effective income tax rate of 22% to 23%.
Q4 2023 net earnings attributable to Snap-on were $255.3 million, or $4.75 per diluted share, versus $238.9 million, or $4.42, in Q4 2022.
Q4 organic sales rose 2.2%, while Snap-on Tools Group segment sales fell 5.7% organically.
Full-year 2023 net earnings attributable to Snap-on were $1,011.1 million, compared with $911.7 million in 2022.
For 2024, capital expenditures are projected at $100 million to $110 million and the effective tax rate at 22% to 23%.
EastGroup Properties reported fourth-quarter 2023 diluted EPS of $1.35 and FFO of $2.03 per share, up 11.5% from a year earlier, with 98.7% of its operating portfolio leased at year-end. The company also gave 2024 guidance of $8.17 to $8.37 in FFO per share, compared with $7.79 for 2023, which the filing says reflects 6.2% growth at the midpoint. For shareholders, the results and outlook are the key figures, along with a declared quarterly dividend of $1.27 per share.
Q4 2023 diluted EPS was $1.35, compared with $0.89 in Q4 2022; FFO was $2.03 per share, compared with $1.82.
Full-year 2023 FFO was $7.79 per share, up 11.3% from $7.00; diluted EPS was $4.42, compared with $4.36.
2024 guidance: EPS of $4.09 to $4.29 and FFO of $8.17 to $8.37 per share.
Quarterly cash dividend of $1.27 per share declared, the company's 176th consecutive quarterly dividend.
Qualys reported fourth-quarter and full-year 2023 results that showed revenue and profit growth, and it guided to 2024 revenue growth of 8% to 10%, below the 13% it posted for 2023. The company also raised its share repurchase program by $200 million, which gives shareholders a larger buyback authorization.
Q4 2023 revenue was $144.6 million, up 10% from $130.8 million; GAAP diluted EPS was $1.08 versus $0.74 a year earlier.
Full-year 2023 revenue was $554.5 million, up 13%; GAAP diluted EPS was $4.03 versus $2.74 in 2022.
2024 guidance: revenue of $600 million to $610 million (8% to 10% growth) and non-GAAP diluted EPS of $4.95 to $5.27.
Q4 operating cash flow fell 23% to $33.8 million, and the share repurchase increase is $200 million.
The New York Times Company reported fourth-quarter 2023 total revenues of $676.2 million, up 1.3% from a year earlier, and diluted EPS of $0.66 versus $0.43. Operating profit rose 38.7% to $129.0 million, and the board raised the quarterly dividend by $.02 to $.13 per share, payable April 18, 2024. The company also guided to first-quarter 2024 digital-only subscription revenue growth of 11% to 14% and adjusted operating cost growth of 5% to 7%.
Q4 2023 operating profit was $129.0 million, up 38.7%; adjusted operating profit was $154.0 million, up 8.5%.
Full-year 2023 diluted EPS was $1.40 versus $1.04 in 2022; free cash flow was $337.9 million versus $113.7 million.
The company added approximately 300,000 net digital-only subscribers in Q4, ending with 9.70 million.
Quarterly dividend declared at $.13 per share, up from $.11, payable April 18, 2024 to holders of record on April 2, 2024.
American Assets Trust reported fourth-quarter and full-year 2023 results, with revenue, net income and FFO per diluted share all higher than in 2022. Full-year total revenue was $441.2 million versus $422.6 million, and FFO per diluted share rose 3% to $2.40. The company introduced 2024 FFO per diluted share guidance of $2.19 to $2.33, a midpoint of $2.26, and the filing does not compare this with any prior guidance.
Q4 2023 net income to common stockholders was $10.5 million, or $0.17 per diluted share, versus $9.6 million, or $0.16, in Q4 2022.
Full-year 2023 FFO per diluted share was $2.40, up 3% from $2.34; Q4 FFO per diluted share was $0.57, up 2% from $0.56.
2024 FFO per diluted share guidance is $2.19 to $2.33, with a midpoint of $2.26.
A first-quarter 2024 dividend of $0.335 per share is payable March 21, 2024 to holders of record on March 7, 2024.
Fortinet reported fourth-quarter 2023 revenue of $1.42 billion, up 10.3% from a year earlier, and full-year 2023 revenue of $5.30 billion, up 20%. GAAP diluted earnings per share were $0.40 in the quarter, flat year over year, while full-year GAAP diluted earnings per share rose 38% to $1.46. The company also gave first-quarter and full-year 2024 guidance, including full-year 2024 revenue of $5.715 billion to $5.815 billion.
Q4 2023 revenue of $1.42 billion, up 10.3%; product revenue fell 9.6% to $488.1 million while service revenue rose 24.8% to $927.0 million
Full-year 2023 GAAP diluted EPS of $1.46, up 38%; Q4 GAAP diluted EPS of $0.40, unchanged from the prior-year quarter
Q1 2024 revenue guidance of $1.300 billion to $1.360 billion; full-year 2024 revenue guidance of $5.715 billion to $5.815 billion
Share repurchases of $1.50 billion in 2023; about $1.03 billion remained available as of February 6, 2024
AMETEK reported record fourth-quarter 2023 sales of $1.73 billion, up 6.5%, and adjusted diluted earnings of $1.68 per share, up 11%, with full-year 2023 sales of $6.60 billion. The company expects 2024 sales to rise by low double digits and adjusted earnings of $6.70 to $6.85 per share, an increase of 5% to 7%, which gives shareholders a forward profit range.
Q4 2023 sales $1.73 billion, up 6.5%; operating margin 25.7%
Lear reported fourth-quarter and full-year 2023 results on February 6, 2024, with sales and earnings higher than in 2022. The company also gave 2024 guidance of $24.0 billion to $24.6 billion in net sales and $1,155 million to $1,305 million in core operating earnings. Shareholders get a year-over-year profit increase plus a forward outlook, with the company also reporting $313 million in full-year share repurchases.
Q4 2023 sales were $5.8 billion, up 9% from $5.4 billion; diluted EPS was $2.18 vs $1.97 a year earlier
Full-year 2023 sales were $23.5 billion, up 12%; diluted EPS was $9.68 vs $5.47 and adjusted EPS was $12.02 vs $8.72
2024 outlook: net sales of $24.0 billion to $24.6 billion; core operating earnings of $1,155 million to $1,305 million
Full-year 2023 free cash flow was $638 million and the company repurchased $313 million of its shares
NAPCO Security Technologies reported fiscal second-quarter 2024 results for the quarter ended December 31, 2023, with net sales up 12% to $47.5 million and net income up 221% to $12.6 million, or $0.34 per diluted share. The board also declared a quarterly dividend of $0.10 per share, a 25% increase over the prior $0.08 payment, payable March 22, 2024.
Net sales rose 12% to $47.5 million versus $42.3 million a year earlier, the company's highest quarterly sales as stated in the filing.
Net income rose 221% to $12.6 million, or $0.34 per diluted share, compared with $3.9 million, or $0.11 per diluted share.
Recurring service revenue rose 25% to $18.5 million, with a 90% gross margin, and the company reported no debt as of December 31, 2023.
Quarterly dividend of $0.10 per share is payable March 22, 2024, to holders of record on March 1, 2024.
United States Lime & Minerals reported fourth quarter and full year 2023 results, with revenue and net income both higher than in 2022, and raised its quarterly dividend to $0.25 per share from $0.20. CEO Timothy W. Byrne said soft construction demand, particularly from commercial building, is expected to continue through at least the first half of 2024.
Q4 2023 revenue was $65.7 million, up 12.7% from $58.3 million; net income was $17.0 million, or $2.98 per diluted share, versus $1.90 a year earlier.
Full year 2023 revenue was $281.3 million, up 19.1% from $236.2 million; net income was $74.5 million, or $13.06 per diluted share, versus $8.00 in 2022.
Quarterly cash dividend increased to $0.25 per share, payable March 15, 2024 to shareholders of record on February 23, 2024.
Management expects soft construction demand to continue through at least the first half of 2024.
Grainger reported fourth-quarter 2023 sales of $4.0 billion, up 5.1%, and reported diluted EPS of $7.89, up 4.7%. Excluding a loss on the divestiture of E & R Industrial Sales, adjusted diluted EPS was $8.33, up 16.7%. The company also issued 2024 guidance, including net sales of $17.2 billion to $17.7 billion and diluted EPS of $38.00 to $40.50.
Q4 2023 reported operating margin was 13.9%, down 40 basis points; adjusted operating margin was 14.6%, up 80 basis points
Full-year 2023 sales were $16.5 billion, up 8.2%, and reported diluted EPS was $36.23, up 20.5%
2024 guidance projects net sales of $17.2 billion to $17.7 billion and diluted EPS of $38.00 to $40.50 on an adjusted basis
Q4 2023 free cash flow was $477 million; the company returned $437 million to shareholders through dividends and buybacks in the quarter
Kirby reported fourth-quarter 2023 net earnings attributable to Kirby of $61.9 million, or $1.04 per diluted share, up from $37.3 million, or $0.62, a year earlier, on revenue of $799.2 million versus $730.2 million. The company also said it expects 2024 earnings to grow 30% to 40% year over year and projected 2024 operating cash flow of $600 million to $700 million, and Chairman Joseph H. Pyne will retire, with Richard J. Alario succeeding him as chairman at the April 26, 2024 annual meeting.
Q4 2023 diluted EPS of $1.04 vs. $0.62 in Q4 2022; revenue of $799.2 million vs. $730.2 million
Full-year 2023 diluted EPS of $3.72 vs. $2.03 in 2022; revenue of $3.1 billion vs. $2.8 billion
2024 outlook: earnings growth of 30% to 40% and operating cash flow of $600 million to $700 million
Joseph H. Pyne retires as chairman; Richard J. Alario becomes chairman effective April 26, 2024
St. Joe issued a press release on February 1, 2024 reporting record 2023 operating activity across its residential, hospitality and commercial segments. The release gives operating metrics only, with no revenue, profit or EPS figures, and says full fourth quarter and full year 2023 results will be released after the market close on February 21, 2024.
1,704 total sales of homes and homesites in 2023, the most in company history
Watersound Club membership rose by 713 members to 3,317 at year-end, a record increase
Commercial portfolio of 1,028,831 square feet under lease, about 95% occupancy, with 44 new leases signed
Full fourth quarter and 2023 financial results expected after market close on February 21, 2024
Deckers reported record third-quarter fiscal 2024 results for the quarter ended December 31, 2023, with net sales up 16.0% to $1.560 billion and diluted EPS of $15.11, compared with $10.48 a year earlier. The company raised its full-year fiscal 2024 revenue and diluted EPS guidance, which indicates higher expected profit for shareholders.
Net sales rose 16.0% to $1.560 billion from $1.346 billion; DTC net sales rose 22.7% and wholesale rose 8.6%.
Diluted EPS was $15.11 versus $10.48; gross margin was 58.7% versus 53.0%.
Fiscal 2024 diluted EPS guidance was raised to $26.25 to $26.50, and net sales are now expected to be about $4.15 billion.
The company repurchased about $99.7 million of its stock in the quarter and had about $1.046 billion remaining under its repurchase authorization as of December 31, 2023.
HII reported fourth quarter 2023 revenue of $3.2 billion, up 13% from a year earlier, and diluted earnings per share of $6.90 versus $3.07. For full year 2023, revenue reached a record $11.5 billion, up 7.3%, and diluted EPS was $17.07 versus $14.44. The company also issued 2024 outlook calling for shipbuilding revenue of $8.8 billion to $9.1 billion and free cash flow of $600 million to $700 million.
Q4 2023 operating income was $312 million, with operating margin of 9.8% versus 3.7% a year earlier; segment operating income was lifted by the sale of a court judgment and an insurance claim settlement
Full year 2023 net earnings were $681 million, up from $579 million in 2022; free cash flow was $692 million
New contract awards in 2023 were about $12.5 billion, bringing total backlog to about $48.1 billion as of December 31, 2023
FY24 outlook: shipbuilding revenue of $8.8 billion to $9.1 billion, Mission Technologies revenue of $2.7 billion to $2.75 billion, and free cash flow of $600 million to $700 million
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.